Gaspari Nutrition

Halodrol

Serving
1 Tablet(s)
Per container
30
Form
tablet
UPC
646511023529
DSLD
Formula hash
74c85a163e4a
Brand context
CA
Catalog
315
products
With avoid flag
12
products
FDA recalls
0
history
CAERS
2
reports
Caution-flaggedObjective label signals
Flagged excipients
2
0 avoid · 2 caution
FDA recalls
0
no recall history
CAERS reports
2
FDA consumer events
Certifications
0
none recorded
2 excipients carry authority-caution citations. · Every flag below links to the authority's published citation.

Supplement Facts

1 active ingredients
IngredientAmount% DV
Proprietary Anabolic Blend
Proprietary Blend (Combination)other
250 mg
Flagged excipients

2 flagged · authority citations

  • ◐ CAUTIONFD&C Blue # 2
    color

    Banned from direct food use in Norway; restricted in EU under Commission Regulation 1333/2008. FDA permits under 21 CFR 74.102 with labeling requirement.

  • ◐ CAUTIONFD&C Yellow #5
    color

    EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).

FDA CAERS · adverse event context
2
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Microcrystalline Cellulose · Phosphatidylcholine · Hydroxypropyl Beta Cyclodextrin · Phytosterols · Magnesium Stearate · Silica

Chemically equivalent

Same formula, different brand

Products with identical sorted (ingredient, amount) tuples.